Sun Pharma Adv Resrc Key Ratios
NSE: SPARC | BSE: 532872
₹190.16
As on 20-Nov-2026IST
Market cap
₹6,189 Cr
Revenue (TTM)
₹1,932 Cr
P/E Ratio
3.8
P/B Ratio
4.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -24.77 | 282.06 | 3,140.97 | 105.09 | 80.89 |
| EBIT | -31.69 | 29.77 | 733.06 | 98.50 | 55.14 |
| Net Profit | -17.16 | 67.65 | 712.95 | 104.03 | 54.62 |
| EPS | -17.17 | 67.64 | 708.35 | 104.02 | 49.58 |
| Book Value | -- | -- | 704.47 | 37.52 | 53.06 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| -312.40 | -235.05 | 84.26 | 84.54 | -467.54 |
| Net Margin
| -252.26 | -197.42 | 82.58 | 82.17 | -465.64 |
| Return on equity
| 52.40 | 2.69 | 118.53 | 276.89 | 0.00 |
| Return on Capital
| -89.82 | -112.90 | -- | 163.94 | -311.92 |
| Return on Assets
| -6.44 | -27.84 | 163.91 | 124.17 | -80.88 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.42 | -1.19 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
--
|
163.94
|
-311.92
|
-112.35
|
-41.91
|
|
Peer Median
|
--
|
14.77
|
14.72
|
18.85
|
--
|
ROE
118.53
Higher than Peers by 107.77
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
118.53
|
276.89
|
--
|
-121.28
|
-43.41
|
|
Peer Median
|
10.76
|
12.35
|
11.67
|
14.92
|
--
|
ROA
163.91
Higher than Peers by 157.19
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
163.91
|
124.17
|
-80.88
|
-57.63
|
-26.81
|
|
Peer Median
|
6.72
|
6.87
|
7.86
|
9.06
|
--
|
EBIT Margin
84.26
Higher than Peers by 71.51
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
84.26
|
84.54
|
-467.54
|
-548.82
|
-94.57
|
|
Peer Median
|
12.75
|
13.55
|
15.03
|
14.71
|
--
|
Net Margin
82.58
Higher than Peers by 73.52
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
82.58
|
82.17
|
-465.64
|
-368.72
|
-89.16
|
|
Peer Median
|
9.06
|
8.30
|
9.33
|
8.49
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
0.00
|
83.20
|
-459.99
|
-496.00
|
-88.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
3,140.97
Higher than Peers by 3,132.12
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
3,140.97
|
2,518.47
|
-5.00
|
-68.36
|
--
|
|
Peer Median
|
8.85
|
17.50
|
10.27
|
11.85
|
--
|
EBIT Growth
735.77
Higher than Peers by 718.53
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
735.77
|
573.44
|
19.07
|
-83.60
|
--
|
|
Peer Median
|
17.24
|
24.88
|
24.15
|
28.00
|
--
|
Net Profit Growth
712.95
Higher than Peers by 695.70
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
712.95
|
553.48
|
11.55
|
-73.96
|
--
|
|
Peer Median
|
17.25
|
36.93
|
30.29
|
36.51
|
--
|
EPS Growth
708.35
Higher than Peers by 698.48
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
708.35
|
553.48
|
11.55
|
-73.96
|
--
|
|
Peer Median
|
9.87
|
26.79
|
24.50
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
--
|
717.12
|
-272.52
|
-75.48
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
--
|
0.42
|
-1.19
|
0.37
|
0.00
|
|
Peer Median
|
0.04
|
0.24
|
0.23
|
0.20
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
--
|
0.42
|
-0.73
|
0.37
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
7.65
Higher than Peers by 5.89
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
7.65
|
2.47
|
0.07
|
1.02
|
2.54
|
|
Peer Median
|
1.76
|
1.83
|
1.79
|
1.96
|
--
|
Quick Ratio
7.65
Higher than Peers by 6.45
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
7.65
|
2.47
|
0.07
|
1.02
|
2.54
|
|
Peer Median
|
1.20
|
1.19
|
1.47
|
1.44
|
--
|
Interest Coverage
58.05
Higher than Peers by 49.93
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
58.05
|
46.50
|
-36.92
|
-227.27
|
-28.15
|
|
Peer Median
|
8.12
|
7.74
|
9.42
|
8.58
|
--
|
Operating Efficiency
Debtors to sales
1.10
Lower than Peers by 24.20
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
1.10
|
0.44
|
22.37
|
20.56
|
13.70
|
|
Peer Median
|
25.30
|
23.05
|
25.82
|
26.12
|
--
|
Asset Turnover
1.94
Higher than Peers by 1.27
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
1.94
|
1.50
|
0.17
|
0.11
|
0.29
|
|
Peer Median
|
0.66
|
0.79
|
0.75
|
0.77
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
--
|
2.36
|
80.33
|
116.55
|
50.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
3.78
Lower than Peers by 38.69
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
3.78
|
2.39
|
--
|
--
|
--
|
|
Peer Median
|
42.48
|
42.48
|
39.70
|
33.48
|
--
|
Price / Book Value
4.29
Higher than Peers by 0.29
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
4.29
|
2.78
|
-22.14
|
95.47
|
11.36
|
|
Peer Median
|
4.00
|
4.12
|
3.72
|
4.21
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.20
|
0.10
|
0.16
|
0.21
|
--
|
EV/EBITDA
3.04
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
3.04
|
2.66
|
-15.74
|
-31.93
|
-28.11
|
|
Peer Median
|
--
|
32.33
|
30.23
|
29.90
|
--
|
Market Cap
6,189
Lower than Peers by 3,104
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sun Pharma Adv Resrc
|
6,189
|
3,719
|
4,803
|
12,006
|
5,824
|
|
Peer Median
|
9,293
|
4,877
|
4,851
|
2,099
|
--
|